CD274 and neoplasm: Although this is still subject to further investigations, predictors of the clinical efficacy of ICIs appear to include high membranous PD-L1 levels of expression, high tumor mutational burden, mismatch repair proteins deficiency, microsatellite instability, and infiltrating leukocyte cells.